All lobbying filings

MONUMENT ADVOCACY

Lobbying for CENCORA · Pharmaceutical Services

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

Pennsylvania

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; S. 3822, Break Up Big Medicine Act, MFN Drug pricing issues, including CMMI models; HHS 340B pilot program, Affordability and consolidation issues, 2026 Medicare Physician Fee Schedule issues.

Bills named in this filing 3

H.R. 3164
Ensuring Community Access to Pharmacist Services Act
S. 2464
Community Investment and Prosperity Act
S. 3822
Break Up Big Medicine Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.